How many insider trades does FilingIQ track for PEPG?

FilingIQ tracks 118 Form 4 insider transactions for PEPG (PepGen Inc.), covering filings from May 6, 2022 onwards. 16 of those were filed in the last 90 days.

Are PEPG insiders net buyers or net sellers?

Across the full Form 4 history for PEPG, 13 transactions (11%) were open-market purchases and 30 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PEPG insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PEPG in?

PepGen Inc. (PEPG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $448.93M.

PEPG insider trading

NasdaqGS Healthcare

PepGen Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

118

Last 90 days

Buys / sells

11% / 25%

Market cap

$448.93M

About PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.

Company website: pepgen.com

PEPG insider activity at a glance

FilingIQ has scored 118 insider transactions for PEPG since May 6, 2022. The most recent filing in our index is dated Mar 4, 2026.

Across the full history, 13 open-market purchases and 30 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PEPG insider trades is 58.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PEPG trades on FilingIQ Raw filings on SEC EDGAR

Latest PEPG Form 4 filings

McArthur James G President and CEO

P Apr 8, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding PEPG

Samsara BioCapital, LLC

$7.96M · 1.6% of AUM

Frequently asked

How many insider trades does FilingIQ track for PEPG?: FilingIQ tracks 118 Form 4 insider transactions for PEPG (PepGen Inc.), covering filings from May 6, 2022 onwards. 16 of those were filed in the last 90 days.
Are PEPG insiders net buyers or net sellers?: Across the full Form 4 history for PEPG, 13 transactions (11%) were open-market purchases and 30 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PEPG insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PEPG in?: PepGen Inc. (PEPG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $448.93M.

Methodology & sources

Every PEPG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.